1,675
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis

, , , , , , & show all
Pages 1-11 | Received 20 Jul 2018, Accepted 21 Oct 2018, Published online: 21 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alana B. Byrne, Cybele C. García, Elsa B. Damonte & Laura B. Talarico. (2022) Murine models of dengue virus infection for novel drug discovery. Expert Opinion on Drug Discovery 17:4, pages 397-412.
Read now

Articles from other publishers (18)

Yong He, Jiahui Zhou, Huizhan Gao, Chuanfeng Liu, Peng Zhan & Xinyong Liu. (2024) Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses. European Journal of Medicinal Chemistry 265, pages 116069.
Crossref
Chao Qin, Taolin Xie, Wayne Wei Yeh, Ali Can Savas & Pinghui Feng. (2023) Metabolic Enzymes in Viral Infection and Host Innate Immunity. Viruses 16:1, pages 35.
Crossref
Yuanqi Yang, Yanni Gao, Lujie Zhang, Xing Liu, Yangyang Sun, Juan Bai & Ping Jiang. (2023) Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase. Veterinary Research 54:1.
Crossref
Chao-Fu Yang, Chun-Che Liao, Hung-Wei Hsu, Jian-Jong Liang, Chih-Shin Chang, Hui-Ying Ko, Rue-Hsin Chang, Wei-Chun Tang, Ming-Hao Chang, I-Hsuan Wang & Yi-Ling Lin. (2023) Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission. Journal of Biomedical Science 30:1.
Crossref
Yongzhe Zhu, Shenglin Chen, Qilin Lurong & Zhongtian Qi. (2023) Recent Advances in Antivirals for Japanese Encephalitis Virus. Viruses 15:5, pages 1033.
Crossref
Kumar Saurabh Srivastava, Vandana Jeswani, Nabanita Pal, Babita Bohra, Vaishali Vishwakarma, Atharva Ashish Bapat, Yamini Prashanti Patnaik, Navin Khanna & Rahul Shukla. (2023) Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines. Vaccines 11:4, pages 742.
Crossref
Gema Lozano‐Terol, Julia Gallego‐Jara, Rosa Alba Sola‐Martínez, Álvaro Ortega, Adrián Martínez Vivancos, Manuel Cánovas Díaz & Teresa de Diego Puente. (2022) Regulation of the pyrimidine biosynthetic pathway by lysine acetylation of E. coli OPRTase . The FEBS Journal 290:2, pages 442-464.
Crossref
Claudia Soledad Sepúlveda, Cybele Carina García & Elsa Beatriz Damonte. (2022) Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy. Microorganisms 10:8, pages 1631.
Crossref
Satoko Yamaoka, Carla M. Weisend, Vaille A. Swenson & Hideki Ebihara. (2022) Development of accelerated high-throughput antiviral screening systems for emerging orthomyxoviruses. Antiviral Research 200, pages 105291.
Crossref
Evelyne Kohli, Sébastien Causse, Valentin Baverel, Laurence Dubrez, Natalia Borges-Bonan, Oleg Demidov & Carmen Garrido. (2021) Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives. Microbiology and Molecular Biology Reviews 85:4.
Crossref
Ming-Hao Yang, Chung-Chi Hu, Chi-Hzeng Wong, Jian-Jong Liang, Hui-Ying Ko, Meng-Hsun He, Yi-Ling Lin, Na-Sheng Lin & Yau-Heiu Hsu. (2021) Convenient Auto-Processing Vector Based on Bamboo Mosaic Virus for Presentation of Antigens Through Enzymatic Coupling. Frontiers in Immunology 12.
Crossref
Cyril Sobolewski & Noémie Legrand. (2021) Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Biomolecules 11:7, pages 1049.
Crossref
Érica Erlanny da Silva Rodrigues, Hannah Maus, Stefan Josef Hammerschmidt, Alessia Ruggieri, Elane Conceição dos Santos, Ênio José Bassi, Leticia Anderson, Pedro Gregório Vieira Aquino, João Xavier de Araújo-Júnior, Fenju Wei, Xinyong Liu, Peng Zhan, Tanja Schirmeister & Edeildo Ferreira da Silva-Júnior. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines 233 295 .
Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof & Juan C. de la Torre. (2020) Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro. Viruses 12:8, pages 821.
Crossref
Evan R. Abt, Ethan W. Rosser, Matthew A. Durst, Vincent Lok, Soumya Poddar, Thuc M. Le, Arthur Cho, Woosuk Kim, Liu Wei, Janet Song, Joseph R. Capri, Shili Xu, Nanping Wu, Roger Slavik, Michael E. Jung, Robert Damoiseaux, Johannes Czernin, Timothy R. Donahue, Arnon Lavie & Caius G. Radu. (2020) Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide Metabolism. Cell Chemical Biology 27:2, pages 197-205.e6.
Crossref
Gong Mei-jiao, Li Shi-fang, Chang Yan-yan, Shao Jun-jun, Sun Yue-feng, Ren Ting-ting, Zhang Yong-guang & Chang Hui-yun. (2019) Antiviral effects of selected IMPDH and DHODH inhibitors against foot and mouth disease virus. Biomedicine & Pharmacotherapy 118, pages 109305.
Crossref
Juan-Carlos Saiz. (2019) Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go. Pharmaceuticals 12:3, pages 127.
Crossref
Evan R. Abt, Ethan W. Rosser, Matthew A. Durst, Soumya Poddar, Vincent Lok, Liu Wei, Woosuk Kim, Janet Song, Joseph R. Capri, Thuc M. Le, Roger Slavik, Michael E. Jung, Robert Damoiseaux, Johannes Czernin, Timothy R. Donahue, Arnon Lavie & Caius G. Radu. (2019) Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide Metabolism. SSRN Electronic Journal.
Crossref